Ontario government reports 321 new COVID-19 cases, 2 deaths

WATCH ABOVE: Ontario's chief medical officer provides a COVID-19 update Tuesday

The Ontario government is reporting 321 new cases of COVID-19 and two more deaths linked to the virus.

Tuesday’s case count is slightly lower than Monday’s, which saw 325 new infections reported.

Provincial officials noted two more people died on Monday, bringing the total number of people dead to 9,409.

Read more: Ontario business groups call for COVID-19 vaccine certificate system to avoid lockdown

There are currently 100 patients with COVID-19 in general hospital wards. There are 109 people in intensive care units and 72 of those ICU patients are on ventilators.

For the first time on Tuesday, provincial officials started including as part of their daily COVID-19 information data portal about the vaccination status of those hospitalized due to COVID-19.

Story continues below advertisement

They noted the new dataset will grow and improve over time as more information is collected. However, a preliminary gathering of data showed 13 people in general hospital wards due to COVID were fully vaccinated while 48 were either unvaccinated or partially vaccinated. For those in ICUs, three were fully vaccinated while 13 were unvaccinated or partially vaccinated.

On Monday, 16,479 COVID-19 tests were conducted and 1.7 per cent of those tests came back positive.

Read more: Ontario reports 325 COVID-19 cases, 0 deaths

According to the latest provincial data report, 96 new cases were recorded in Toronto, 31 in Peel Region, 31 in Hamilton, 30 in York Region and 22 in Windsor. The rest of the public health units had less than 20 new cases each.

It was also reported 200 cases were deemed resolved on Monday. To date, 541,222 of the 553,125 people in Ontario who tested positive for coronavirus have had their cases classified as resolved.

The government reported as of late Monday, 81.05 per cent of Ontario residents 12 and older have received at least one of the two COVID-19 Pfizer-BioNTech, Moderna or Oxford-AstraZeneca vaccine doses while 71.95 per cent received two doses.

Story continues below advertisement
Story continues below advertisement

Sponsored content